The COVID-19 pandemic has created a unique challenge to test whether extracorporeal membrane oxygenation (ECMO) can increase the survival of critically ill patients with severe acute respiratory distress syndrome (ARDS). Emerging research shows a mortality benefit for COVID-19 patients with ARDS who are supported with ECMO. But which types of patients benefit most, and under which conditions?

Dutch intensive care physician and researcher Heder de Vries, shares his insights into the implementation of Transpulmonary pressure monitoring.

Annually, there are millions of cardiac arrest events, all with low percent survival. Recent randomized controlled trials suggest extracorporeal cardiopulmonary resuscitation (eCPR) may provide a survival benefit in carefully selected patients with cardiac arrest.

Using the electrical activity of the diaphragm (Edi) to evaluate ICU patients’ need for respiratory support is a valuable and often superior complement to standard monitoring parameter, according to senior respiratory consultant Sten Borgström.

Monitoring the strength of the patient's breathing effort, titrating the sedation, and selecting the correct mode of ventilation is vital when transitioning from controlled to assisted ventilation.

Professor Salvatore Grasso, Head of the Department of Anesthesia and Resuscitation at the Faculty of Medicine and Surgery of the University of Bari Aldo Moro Polyclinic, tells his story about the worst health care situation in Italy. Watch the video and learn what he experienced firsthand during the treatment of severely ill patients, at this time, infected by an unknown virus.

Acute respiratory distress syndrome (ARDS) is a serious lung condition that causes low blood oxygen. The incidence of ARDS varies widely.

The key to having less sedated and actively participating patients is to be able to meet their breathing needs. To try and sustain their natural breathing effort as much as possible.

Everyone is at risk of developing sepsis. Globally, up to 50 million people are affected by sepsis, every year. Every 2.8 seconds, one patient dies from sepsis and associated complications. Often, it can be prevented by vaccination, clean water and hygiene, safe childbirth, and preventing hospital-acquired infections (HAIs). However, sepsis is often underdiagnosed, especially at an early stage where treatments are more successful.

The presence of diaphragm weakness significantly increases the risk of difficult weaning, prolonged weaning and hospital mortality, says Dr Ewan Goligher, referencing a recent study on the topic.

Hemodynamic insights present valuable knowledge for physicians. In the OR, patients undergoing surgeries always benefit from close vigilance. Optimal perioperative fluid administration is the key for a successful recovery. In the ICU, the life of critically ill patient depends on the right decision for the next therapeutic step.

Respiratory support is a lifesaving intervention in the ICU, but without the right balance it also increases the risk of detrimental outcomes.1,2 This is when diaphragm monitoring can help, because it is a marker of outcomes such as hospital mortality and prolonged weaning. Furthermore, it can help you make more informed therapy decisions throughout respiratory treatment.

Ease of use can have an impact on patient safety and staff routine. This article will provide you access to a study about the correlation between ease of use and patient safety. You will also be able to download a form to help you in the comparison process when investing in new equipment.

Beyond Basic - with advanced hemodynamic parameters. Learn more about blood pressure, blood flow, preload, afterload, contractility, and pulmonary edema parameters.